216 related articles for article (PubMed ID: 11842446)
21. Neurotoxic effects of +/-fenfluramine and phenteramine, alone and in combination, on monoamine neurons in the mouse brain.
McCann UD; Yuan J; Ricaurte GA
Synapse; 1998 Nov; 30(3):239-46. PubMed ID: 9776127
[TBL] [Abstract][Full Text] [Related]
22. Preexposure to MDMA ("Ecstasy") delays acquisition but facilitates MDMA-induced reinstatement of amphetamine self-administration behavior in rats.
Morley KC; Cornish JL; Li KM; McGregor IS
Pharmacol Biochem Behav; 2004 Oct; 79(2):331-42. PubMed ID: 15501310
[TBL] [Abstract][Full Text] [Related]
23. Early loss of dopaminergic terminals in striosomes after MDMA administration to mice.
Granado N; Escobedo I; O'Shea E; Colado I; Moratalla R
Synapse; 2008 Jan; 62(1):80-4. PubMed ID: 17960765
[TBL] [Abstract][Full Text] [Related]
24. Abnormal ACTH and prolactin responses to fenfluramine in rats exposed to single and multiple doses of MDMA.
Poland RE; Lutchmansingh P; McCracken JT; Zhao JP; Brammer GL; Grob CS; Boone KB; Pechnick RN
Psychopharmacology (Berl); 1997 Jun; 131(4):411-9. PubMed ID: 9226745
[TBL] [Abstract][Full Text] [Related]
25. An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine.
Sprague JE; Everman SL; Nichols DE
Neurotoxicology; 1998 Jun; 19(3):427-41. PubMed ID: 9621349
[TBL] [Abstract][Full Text] [Related]
26. The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine.
Miller DB; O'Callaghan JP
Mol Neurobiol; 1995; 11(1-3):177-92. PubMed ID: 8561961
[TBL] [Abstract][Full Text] [Related]
27. Approach to a social stranger is associated with low central nervous system serotonergic responsivity in female cynomolgus monkeys (Macaca fascicularis).
Manuck SB; Kaplan JR; Rymeski BA; Fairbanks LA; Wilson ME
Am J Primatol; 2003 Dec; 61(4):187-94. PubMed ID: 14669270
[TBL] [Abstract][Full Text] [Related]
28. The neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine on serotonin, dopamine, and GABA-ergic terminals: an in-vitro autoradiographic study in rats.
Armstrong BD; Noguchi KK
Neurotoxicology; 2004 Dec; 25(6):905-14. PubMed ID: 15474609
[TBL] [Abstract][Full Text] [Related]
29. Acute effects of dexfenfluramine (d-FEN) and methylenedioxymethamphetamine (MDMA) before and after short-course, high-dose treatment.
Frederick DL; Ali SF; Gillam MP; Gossett J; Slikker W; Paule MG
Ann N Y Acad Sci; 1998 May; 844():183-90. PubMed ID: 9668676
[TBL] [Abstract][Full Text] [Related]
30. In vivo correlates of central serotonin function after high-dose fenfluramine administration.
Baumann MH; Ayestas MA; Rothman RB
Ann N Y Acad Sci; 1998 May; 844():138-52. PubMed ID: 9668672
[TBL] [Abstract][Full Text] [Related]
31. Behavioural and neuroendocrine responses to D-fenfluramine in rats treated with neurotoxic amphetamines.
Series HG; le Masurier M; Gartside SE; Franklin M; Sharp T
J Psychopharmacol; 1995 Jan; 9(3):214-22. PubMed ID: 22297760
[TBL] [Abstract][Full Text] [Related]
32. Plasma levels of parent compound and metabolites after doses of either d-fenfluramine or d-3,4-methylenedioxymethamphetamine (MDMA) that produce long-term serotonergic alterations.
Bowyer JF; Young JF; Slikker W; Itzak Y; Mayorga AJ; Newport GD; Ali SF; Frederick DL; Paule MG
Neurotoxicology; 2003 Jun; 24(3):379-90. PubMed ID: 12782103
[TBL] [Abstract][Full Text] [Related]
33. Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide.
Freezer A; Salem A; Irvine RJ
Brain Res; 2005 Apr; 1041(1):48-55. PubMed ID: 15804499
[TBL] [Abstract][Full Text] [Related]
34. Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users.
Reneman L; Schilt T; de Win MM; Booij J; Schmand B; van den Brink W; Bakker O
J Psychopharmacol; 2006 May; 20(3):389-99. PubMed ID: 16574713
[TBL] [Abstract][Full Text] [Related]
35. 3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement.
Fantegrossi WE; Ullrich T; Rice KC; Woods JH; Winger G
Psychopharmacology (Berl); 2002 Jun; 161(4):356-64. PubMed ID: 12073162
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of amphetamines-induced neurotoxicity on appetitive and aversive Pavlovian conditioning in mice.
Achat-Mendes C; Ali SF; Itzhak Y
Neuropsychopharmacology; 2005 Jun; 30(6):1128-37. PubMed ID: 15688084
[TBL] [Abstract][Full Text] [Related]
37. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
Camarasa J; Pubill D; Escubedo E
Brain Res; 2006 Sep; 1111(1):72-82. PubMed ID: 16889759
[TBL] [Abstract][Full Text] [Related]
38. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
Shioda K; Nisijima K; Yoshino T; Kuboshima K; Iwamura T; Yui K; Kato S
Neurotoxicology; 2008 Nov; 29(6):1030-6. PubMed ID: 18722468
[TBL] [Abstract][Full Text] [Related]
39. Persistent cerebrovascular effects of MDMA and acute responses to the drug.
Ferrington L; Kirilly E; McBean DE; Olverman HJ; Bagdy G; Kelly PA
Eur J Neurosci; 2006 Jul; 24(2):509-19. PubMed ID: 16836637
[TBL] [Abstract][Full Text] [Related]
40. Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses.
Mueller M; Peters FT; Maurer HH; McCann UD; Ricaurte GA
J Pharmacol Exp Ther; 2008 Oct; 327(1):38-44. PubMed ID: 18591215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
